Canaccord Genuity Group restated their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a report released on Tuesday, Benzinga reports. Canaccord Genuity Group currently has a $15.00 target price on the stock. Separately, JMP Securities reaffirmed a market outperform rating and set a $20.00 price objective on shares of TELA Bio […]
Related Keywords
, Canaccord Genuity Group , Susquehanna International Group , Millennium Management , Nasdaq , Morgan Stanley , Capital Management , Schonfeld Strategic Advisors , Bio Inc , Get Rating , Genuity Group , Strategic Advisors , Ovitex Reinforced Tissue Matrix , Tissue Matrix , Robotic Procedures , Tela Bio , Nasdaq Tela , Tutela , Medical , Reiterated Rating , Canaccord Genuity Group Inc ,
comparemela.com © 2020. All Rights Reserved.